Cargando…
Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
Autor principal: | Krendyukov, Andriy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492559/ https://www.ncbi.nlm.nih.gov/pubmed/32984026 http://dx.doi.org/10.3389/fonc.2020.01604 |
Ejemplares similares
-
Early access provision: Awareness, educational needs and opportunities to improve oncology patients’ access to care
por: Krendyukov, Andriy, et al.
Publicado: (2022) -
Innovative oncology products: time to revisit the strategy development?
por: Krendyukov, Andriy
Publicado: (2019) -
The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017) -
Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
por: Dalwadi, Shraddha M., et al.
Publicado: (2023) -
Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
por: Krendyukov, Andriy, et al.
Publicado: (2021)